Nycomed extends its Genedata Screener contract

Genedata has signed a multi-year contract extension for the use of the Genedata Screener lead discovery product suite with Nycomed. Under the agreement, Genedata will create a global scientific computing infrastructure for discovery and drug research programs at Nycomed sites worldwide. The number of Genedata Screener users is expected to double under the contract renewal.

Genedata Screener will allow interdisciplinary teams at all of Nycomed’s sites to capture, visualise, analyse and manage large volumes of assay data, independent of instrumentation, technology, volume or location. The effective combination of these findings with data from other corporate sources, accessible through Screener's viewing tools, will provide Nycomed scientists with the range of information they need to enhance their lead finding processes – anywhere on the globe.

Dr Werner Stürmer, Head of HTS at Nycomed, said: ‘Genedata Screener not only improves the efficiency and quality of our screening campaigns, but also has a catalytic impact on our global information network – increasing the number of users and promoting accurate and timely decisions across departments and countries.’

Twitter icon
Google icon icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Analysis and opinion

Robert Roe investigates some of the European projects focusing on preparing today’s supercomputers and HPC programmers for exascale HPC


The Jülich Supercomputing Centre (JSC) at Forschungszentrum Jülich in Germany has been operating supercomputers of the highest performance class since 1987. Tim Gillett talks to Norbert Attig and Thomas Eickermann


Gemma Church investigates how simulation and modelling de-risks the detection and extraction of geothermal energy resources


Robert Roe investigates the importance of upgrading legacy laboratory informatics systems and the benefits this provides to scientists